Aiping Ma

530 total citations
25 papers, 394 citations indexed

About

Aiping Ma is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Aiping Ma has authored 25 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in Aiping Ma's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Tuberous Sclerosis Complex Research (3 papers). Aiping Ma is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Tuberous Sclerosis Complex Research (3 papers). Aiping Ma collaborates with scholars based in China, Germany and United States. Aiping Ma's co-authors include Kai‐Feng Xu, Xinlun Tian, Baiqiang Cai, Hongbing Zhang, Ni Zeng, Frank Petersen, Ji Zhang, Xue Li, Weixun Zhou and Jingyu Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Human Molecular Genetics.

In The Last Decade

Aiping Ma

23 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aiping Ma China 11 148 110 85 63 62 25 394
Hayato Koba Japan 10 180 1.2× 44 0.4× 31 0.4× 49 0.8× 61 1.0× 46 361
Mirando Mršić Croatia 15 96 0.6× 82 0.7× 41 0.5× 135 2.1× 108 1.7× 41 562
Chun‐Liang Chou Taiwan 12 120 0.8× 175 1.6× 69 0.8× 76 1.2× 79 1.3× 26 607
Giammarco Surico Italy 11 59 0.4× 99 0.9× 72 0.8× 118 1.9× 46 0.7× 27 480
Chang‐Suk Kang South Korea 12 41 0.3× 97 0.9× 66 0.8× 22 0.3× 83 1.3× 31 372
Muhlis Cem Ar Türkiye 14 47 0.3× 120 1.1× 29 0.3× 51 0.8× 81 1.3× 113 655
Ryuji Ieki Japan 12 130 0.9× 54 0.5× 59 0.7× 23 0.4× 79 1.3× 34 357
Tatsunori Kiriu Japan 13 186 1.3× 119 1.1× 84 1.0× 15 0.2× 17 0.3× 26 460
S. Fabiani Italy 9 49 0.3× 77 0.7× 33 0.4× 19 0.3× 40 0.6× 23 339
Yuhsaku Kanoh Japan 13 66 0.4× 203 1.8× 48 0.6× 17 0.3× 94 1.5× 43 450

Countries citing papers authored by Aiping Ma

Since Specialization
Citations

This map shows the geographic impact of Aiping Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiping Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiping Ma more than expected).

Fields of papers citing papers by Aiping Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aiping Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiping Ma. The network helps show where Aiping Ma may publish in the future.

Co-authorship network of co-authors of Aiping Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Aiping Ma. A scholar is included among the top collaborators of Aiping Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiping Ma. Aiping Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Aiping, Heqing Huang, Xinze Li, et al.. (2025). Association of combined pulmonary fibrosis and emphysema in rheumatoid arthritis with high titer of rheumatoid factor and autoimmunity to the lung. Frontiers in Immunology. 16. 1514552–1514552. 1 indexed citations
3.
Zhang, Liang, et al.. (2024). Interstitial lung abnormality in COPD is inversely associated with the comorbidity of lung cancer. BMC Pulmonary Medicine. 24(1). 506–506. 2 indexed citations
4.
Ma, Aiping, Yan Du, Yi Hu, et al.. (2022). The clinical relevance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic obstructive pulmonary disease with lung cancer. Frontiers in Oncology. 12. 902955–902955. 12 indexed citations
6.
Ma, Aiping, Liang Zhang, Jing Chen, et al.. (2021). High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19. Frontiers in Immunology. 12. 626235–626235. 64 indexed citations
7.
Ma, Aiping, Junping Yin, Yi Hu, et al.. (2020). <p>Serum Levels of Autoantibodies Against Extracellular Antigens and Neutrophil Granule Proteins Increase in Patients with COPD Compared to Non-COPD Smokers</p>. International Journal of COPD. Volume 15. 189–200. 10 indexed citations
9.
Zhang, Tengyue, et al.. (2020). Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need. Science China Life Sciences. 63(5). 774–776. 29 indexed citations
10.
Yang, Dongyong, Na Li, Aiping Ma, et al.. (2020). Identification of Potential Biomarkers of Polycystic Ovary Syndrome via Integrated Bioinformatics Analysis. Reproductive Sciences. 28(5). 1353–1361. 11 indexed citations
11.
Zhang, Xiaohong, Tingting Qin, Yang Xu, et al.. (2019). Ivermectin Augments the In Vitro and In Vivo Efficacy of Cisplatin in Epithelial Ovarian Cancer by Suppressing Akt/mTOR Signaling. The American Journal of the Medical Sciences. 359(2). 123–129. 29 indexed citations
12.
Li, Hao & Aiping Ma. (2017). Changes of cytokines and matrix metalloproteinases in patients with premature rupture of chorioamnion and its clinical significance. 23(20). 73–76. 2 indexed citations
13.
Hu, Yi, Aiping Ma, Shan Lin, Yang Yang, & Guolin Hong. (2017). Novel peptide screened from a phage display library antagonizes the activity of CC chemokine receptor 9. Oncology Letters. 14(6). 6471–6476. 1 indexed citations
14.
Tian, Xinlun, Xue Li, Aiping Ma, et al.. (2015). mTOR Overactivation and Compromised Autophagy in the Pathogenesis of Pulmonary Fibrosis. PLoS ONE. 10(9). e0138625–e0138625. 80 indexed citations
15.
Wang, Wang, Jie Liu, Aiping Ma, et al.. (2014). mTORC1 Is Involved in Hypoxia‐Induced Pulmonary Hypertension Through the Activation of Notch3. Journal of Cellular Physiology. 229(12). 2117–2125. 39 indexed citations
16.
Li, Yan, Xinlun Tian, Aiping Ma, et al.. (2014). Characteristics of serum lipid metabolism in patients with autoimmune pulmonary alveolar proteinosis.. PubMed. 36(6). 645–9. 1 indexed citations
17.
Li, Yan, Xinlun Tian, Aiping Ma, et al.. (2014). [Serum markers in patients with idiopathic pulmonary alveolar proteinosis].. PubMed. 37(7). 497–501. 9 indexed citations
18.
Ma, Aiping, Zai Chang, Haiyong Peng, et al.. (2013). Tsc1 deficiency-mediated mTOR hyperactivation in vascular endothelial cells causes angiogenesis defects and embryonic lethality. Human Molecular Genetics. 23(3). 693–705. 22 indexed citations
19.
Tian, Xinlun, Ruie Feng, Aiping Ma, et al.. (2012). SPC-Cre-ERT2 Transgenic Mouse for Temporal Gene Deletion in Alveolar Epithelial Cells. PLoS ONE. 7(9). e46076–e46076. 15 indexed citations
20.
Xu, Kai‐Feng, Peng Zhāng, Xinlun Tian, et al.. (2012). The role of vascular endothelial growth factor-D in diagnosis of lymphangioleiomyomatosis (LAM). Respiratory Medicine. 107(2). 263–268. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026